“Current Topics in DMPK and the New DDI Draft Guidance”
Crowne Plaza Somerset-Bridgewater Hotel
110 Davidson Avenue
Somerset, New Jersey
April 26, 2012
8:00 am – 3:45 pm
Program
08:00 am
Registration / Continental Breakfast / Vendor Exhibit
09:00 am
Introductory Remarks
Dr. Lian Zhou, Chair, NJDMDG
09:10 am
Drug Metabolism in Chimeric Mice with Humanized Liver [slides (PDF)]
Professor Hiroshi Yamazaki, Showa Pharmaceutical University, Machida, Tokyo
10:00 am
ADME in NAFLD: Genes and Big Jeans Increase the Risk of Adverse Drug Reactions [slides (PDF)]
Professor Nathan Cherrington, Pharmacology & Toxicology, University of Arizona, Tucson, AZ.
10:45 am
Vendor Exhibit & Coffee Break
11:30 am
Clarity on Transporters: Navigating the New FDA Draft Guidance on Drug Interactions [slides (PDF)]
Dr. Sid Bhoopathy, Chief Operating Officer, Absorption Systems, Exton, PA.
12:15 pm
Lunch & Vendor Exhibit
01:45 pm
The 2012 FDA Draft Guidance on Drug-drug Interactions: Enzyme Induction and Beyond [slides (PDF)]
Dr. Michael Sinz, Research Fellow, Metabolism and Pharmacokinetics, Bristol-Myers Squibb
02:30 pm
Vendor Exhibit & Coffee Break
03:00 pm
Update on the Progress of the IQc/FDA/Academia Collaboration on DDI Prediction and Thoughts on the DDI Draft Guidance
Dr. Scott Obach, Senior Research Fellow, Pharmacokinetics, Dynamics, and Drug Metabolism Department, Pfizer
03:45 pm
Program Closure
It is a great honor to serve as Chair for 2024. I look forward to leading this incredible and diverse group of volunteers . . . My goals for 2024 start with supporting our diverse topical groups and committees in organizing exciting seminars.